Inve India ▾

GSP Crop Science share price & results

GSP Crop Science Limited· Chemicals· Commodities

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Gujarat agrochemical maker of insecticides, herbicides, fungicides & PGRs; exports to 37 countries.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue386 ₹ crore+2.4% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin11.0 %0.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit26.0 ₹ crore+13.0% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity17.02 %−3.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-1.12 %+1.6 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)Unavailable+6.2 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Not in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

0 of 1 judged target kept · 13 open · verdicts reflect calls analysed to Q1 FY27.

GSP Crop Science Limited management guidance track record on Inve: 14 targets tracked across analysed earnings calls (0 achieved, 1 missed, 13 open).

TargetOriginal wordingSaidLatest callVerdict
Revenue at Peak Capacity Utilization₹1,900-2,000 crores
Call transcript, Q3 FY26 · 17 Apr 2026
Q3 FY26Q1 FY27:The peak revenue potential figure was not mentioned this quarter. Management confirmed technical capacity utilization is at 70-75%, with scope to grow.
Call transcript, Q1 FY27 · 12 Aug 2026
Ghosted
Overall Growth Rate5-7% higher than last 3 years' growth rate for the upcoming 3 years
Call transcript, Q3 FY26 · 17 Apr 2026
Q3 FY26Q1 FY27:Management provided new, specific guidance of 'around 15%' revenue growth. This is lower than the previous target, which implied a growth rate of 20-22% (based on a historical rate of ~15% + 5-7%).
Call transcript, Q1 FY27 · 12 Aug 2026
Revised Down
Patented Products Revenue Contribution40-50% in next 3 years
Call transcript, Q3 FY26 · 17 Apr 2026
Q3 FY26Q1 FY27:Management reiterated the goal, stating a target to 'almost double' the patented product share over the next 3 years, which aligns with the original 40% target from a 20% base.
Call transcript, Q1 FY27 · 12 Aug 2026
On Track

Source: Inve Guidance Tracker for GSP Crop Science Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

1 of GSP Crop Science Limited's 14 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 11 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹451.85 +4.56% · +₹19.7

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance +26.8% YTD

₹400₹500₹600MarAprMayJunJulAugSeptOctQ3 FY26 — 17 Apr 2026Q1 FY27 — 12 Aug 2026

YTD: ₹356.25 on 24 Mar 2026 → ₹451.85. High ₹643.15 (26 Aug 2026), low ₹337.9 (30 Mar 2026).

Previous close
₹432.15
Market cap
₹2.0k Cr
52-week range
₹337.9 – ₹643.15
Price to earnings (TTM to Jun 2026)
19.32×
Return on equity (TTM to Jun 2026)
17.02%

Overview

Symbol
NSE:GSPCROP
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What GSP Crop Science Limited does

Based on the company's own presentations, annual report and earnings calls.

GSP Crop Science manufactures agrochemical technicals (active ingredients), formulations and intermediates — insecticides, herbicides, fungicides and plant growth regulators — across five manufacturing facilities in India. It reaches customers through domestic B2B supply of technicals and formulations, a domestic B2C branded business routed through a distributor network across 23 Indian states, and exports of registered technical and formulation products to 37 countries including Brazil, the USA and African markets. The company runs an in-house R&D and patent programme and indigenously manufactures several patented technical-formulation combinations, some of which it also white-labels for co-marketing partners.

Segments

  • Domestic B2B
  • Domestic B2C
  • Exports
Manufacturing facilities
5 (Odhav, Kathwada, Nandesari, Samba, Saykha)
Installed formulation capacity
43,672 MT/year (Odhav, Kathwada, Samba)
Installed technical (active ingredient) capacity
15,120 MT/year (Odhav, Nandesari)
Installed intermediates capacity
5,400 MT/year (Saykha)
Domestic distributor network
~5,000 distributors
Indian states covered
23 states
Founded 1985Headquarters Ahmedabad, Gujarat, India Company website

How the price took the results

close before → close after

Q1 FY27
−0.6%
12 Aug
Q3 FY26
+4.2%
17 Apr

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for GSP Crop Science Limited

Free account: one company. Everything above stays public.

Write why you follow GSP Crop Science Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds